Eledon Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $192 | $0 |
Gross Profit | 192 | -79 | ||
EBITDA | -24,733 | -17,964 | -24,608 | -20,431 |
EBIT | -35,928 | -24,696 | -20,510 | |
Net Income | -11,216 | -6,495 | -44,617 | 76,971 |
Net Change In Cash | 0 | 0 | 192 | 0 |
Free Cash Flow | -17,713 | -16,060 | -18,987 | -11,769 |
Cash | 5,741 | 8,496 | 20,549 | 6,751 |
Basic Shares | 77,156 | 771,267 | 59,789 | 55,478 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $120 |
Gross Profit | -359 | -374 | -373 | 120 |
EBITDA | -35,394 | -42,626 | -87,593 | -36,672 |
EBIT | -35,753 | -43,000 | -87,966 | -36,867 |
Net Income | -35,322 | -40,326 | -87,504 | -34,506 |
Net Change In Cash | 0 | 0 | 0 | 120 |
Free Cash Flow | -47,271 | -39,527 | -28,424 | -28,913 |
Cash | 20,549 | 4,612 | 56,409 | 84,833 |
Basic Shares | 48,543 | 24,619 | 14,285 | 14,819 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.13 |
2025-03-31 | -$0.08 |
2024-12-31 | -$0.94 |
